Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy. Group revenues ...

Novo Nordisk's obesity therapy Wegovy put in another strong sales performance in the final quarter of last year, helping to drive group revenue growth of 30% – but don't expect that breakneck ...

These include Wegovy, the brand name of the drug Nissley takes, and Zepbound. Area residents like Nissley who have lost coverage in the last few months say that they’re unsure now how to afford their ...

Dacia, 40, got a prescription for compounded semaglutide (the active drug in Wegovy and Ozempic) about six months later. Both subscriptions are GLP-1 drugs that are used to treat type 2 diabetes and ...